Clinical effectiveness of transaxillary single‐port endoscopic surgery in the treatment of breast benign tumor
World Journal of Surgery · 2024
DOI: 10.1002/wjs.12300 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Surgery, 2024. Verfasst von Qingyu Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery (Breast Surgery), The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Endoscopy, Axilla. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong Province, 2022 Beijing Health Promotion Association-support of the China Breast Surgery Young Physician Research Project, Guangzhou Science, Technology, and Innovation Commission.
Abstract (Originalsprache)
Background
Benign breast lumps affect 10% of women in their lifetimes. Endoscopic surgery could be an alternative surgical technique for benign breast tumors because it is performed through small wounds hidden in inconspicuous areas. The aim of this study was to explore the safety and esthetic effects of endoscopic surgery in the treatment of benign breast disease.
Methods
This retrospective cohort study analyzed 363 patients with benign breast tumors from August 2021 to December 2023 in the Sixth Affiliated Hospital of Sun Yat‐Sen University, of whom 118 underwent transaxillary single‐port endoscopic surgery and 245 underwent traditional open surgery. Clinicopathologic characteristics, surgery type, hospital stay, and complications were analyzed to assess the effectiveness of the procedure for benign breast tumors.
Results
Breast tumor resection was successfully performed in 363 patients by endoscopic surgery or traditional open surgery. Endoscopic procedures demonstrated longer durations of surgery (98.54 ± 35.17 min vs. 70.28 ± 26.06 min, p < 0.01) and postoperative drainage (64.30 ± 34.92 mL vs.18.49 ± 19.86 mL, p < 0.01), but there was less blood loss. The nipple‐areolar complex of the patients who underwent endoscopic resection was significantly more sensitive than the traditional open surgery group. Patients in the endoscopic group reported higher satisfaction with surgical outcome (13.10 ± 1.97 vs. 12.63 ± 1.90, p < 0.01). And there was a significant difference in the wound scar and cosmetic outcome total score between the two groups.
Conclusion
Transaxillary single‐port endoscopic surgery is effective and safe and improves postoperative nipple‐areolar sensation and cosmetic outcome, as compared to the conventional technique.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery (Breast Surgery), The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
- Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
- Department of Pharmacy, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
- Department of Graceland Medical Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
ORCID-Profile: Haiyan Li
Förderung
- Natural Science Foundation of Guangdong Province
- 2022 Beijing Health Promotion Association-support of the China Breast Surgery Young Physician Research Project
- Guangzhou Science, Technology, and Innovation Commission
Zitieren
APA
Yang, Q., Wang, Q., Li, Z., Fu, X., Chen, Z., & Li, H. (2024). Clinical effectiveness of transaxillary single‐port endoscopic surgery in the treatment of breast benign tumor. World Journal of Surgery. https://doi.org/10.1002/wjs.12300
Vancouver
Yang Q, Wang Q, Li Z, Fu X, Chen Z, Li H. Clinical effectiveness of transaxillary single‐port endoscopic surgery in the treatment of breast benign tumor. World Journal of Surgery. 2024. doi:10.1002/wjs.12300
BibTeX
@article{Yang2024,
author = {Yang, Qingyu and Wang, Qinbo and Li, Zongyan and Fu, Xiaoyan and Chen, Zuxiao and Li, Haiyan},
title = {Clinical effectiveness of transaxillary single‐port endoscopic surgery in the treatment of breast benign tumor},
journal = {World Journal of Surgery},
year = {2024},
doi = {10.1002/wjs.12300}
}
EUVIMED